Biogen Inc. (ETR: IDP)
Germany
· Delayed Price · Currency is EUR
146.00
-1.65 (-1.12%)
Jan 9, 2025, 10:18 AM CET
Biogen Revenue
Biogen had revenue of $2.47B USD in the quarter ending September 30, 2024, a decrease of -2.55%. This brings the company's revenue in the last twelve months to $9.61B, down -3.86% year-over-year. In the year 2023, Biogen had annual revenue of $9.84B, down -3.32%.
Revenue (ttm)
$9.61B
Revenue Growth
-3.86%
P/S Ratio
n/a
Revenue / Employee
$1.27M
Employees
7,570
Market Cap
21.31B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | 14.38B | 925.00M | 6.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 20.96B |
Siemens Healthineers AG | 22.36B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.32B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.07B |
SCHOTT Pharma AG & Co. KGaA | 957.09M |
Biogen News
- 6 days ago - Biogen cut to neutral at Piper Sandler on Alzheimer’s headwinds - Seeking Alpha
- 9 days ago - Beaten Down Biogen Stock Looks Attractive At Current Levels - Seeking Alpha
- 12 days ago - Investing pros think these stock-market losers are set to rebound in 2025 - Market Watch
- 17 days ago - Biogen Faces Multiple Analyst Downgrades in December 2024 - GuruFocus
- 27 days ago - Private Medicare plans must cover Biogen's ALS drug, US agency says - Reuters
- 4 weeks ago - Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory? - Benzinga
- 4 weeks ago - Biogen downgraded to hold by Jefferies, Ocrevus royalties cited - Seeking Alpha
- 4 weeks ago - Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown - Benzinga